@article{HBSN19922,
author = {Andrew H. Ko},
title = {Moving from late to early stage disease: lessons learned from erlotinib in pancreatic can},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {7},
number = {5},
year = {2018},
keywords = {},
abstract = {At the time the CONKO-005 trial was originally conceived, there was an inherent rationale to its design; it represented the next logical step in trying to move the needle in the treatment of early-stage pancreatic adenocarcinoma.},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/19922}
}